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Aims: To determine gastric expression of trefoil family factor 2 (TFF2) and MUC6 in Helicobacter pylori
positive and negative subjects, and its association with antralisation at the gastric incisura.
Methods: Gastric biopsies from the antrum, incisura, and body of 76 dyspeptic patients without ulcers
were used for the determination of H pylori infection, histological changes, and epithelial TFF2 and MUC6
expression.
Results: In the foveola, the rates of TFF2 and MUC6 immunostaining were greater in H pylori infected
(n = 27) than in uninfected patients (n = 49) at the antrum (59.3% v 4.1% for TFF2 and 63.0% v 4.1% for
MUC6; both p , 0.001) and incisura (44.4% v 2.0% for TFF2 and 48.1% v 0% for MUC6; both
p , 0.001). In the deeper glands, the rates were also greater in H pylori infected than in uninfected
patients at the incisura (85.2% v 22.4% for both TFF2 and MUC6; p , 0.001). Antral-type mucosa was
present at the incisura in 28 of the 76 patients. TFF2 and MUC6 expression in the foveola and deeper
glands was significantly associated with antral-type mucosa, independent of H pylori status.
Conclusions: Helicobacter pylori infection increases the expression of TFF2 and MUC6 in the gastric
epithelium. Aberrant TFF2 and MUC6 expression is associated with antralisation of gastric incisura.
M
ucins are high molecular weight glycoproteins that
are the major components of the mucous viscous gel
covering the surface of epithelial tissues. To date, 11
distinct human epithelial mucins have been identified.1
Mucins are expressed in a site specific fashion. The gastric
mucosa normally expresses mucins MUC1, MUC5AC, and
MUC6.1–5 These mucins are believed to play an important role
in the protection of the gastric mucosa from extremes of pH,
proteases, toxins, mechanical irritation, and pathogenic
organisms.1–5
‘‘Whether or not trefoil family factor 2 and mucins are
involved in antralisation is unknown’’
Trefoil family factor (TFF) peptides are a relatively newly
discovered family of peptides comprising small secretory
peptides bearing one or more trefoil domain. In humans,
three TFF peptides have been identified, namely: TFF1/pS2
(or breast cancer oestrogen inducible peptide), TFF2/hSP (or
spasmolytic polypeptide), and TFF3/ITF (or intestinal trefoil
factor).6–8 TFFs are mainly synthesised and secreted by mucin
secreting epithelial cells lining the gastrointestinal tract and
are thus closely associated with mucins.1 9 In normal gastric
mucosa, TFF1 co-localises with MUC5AC in the surface/
foveolar epithelium, whereas TFF2 is expressed together with
MUC6 in the mucous cells of the regenerative zone of the
body mucosa and in the antral glands.1 10 11 The role of TFFs
in mucosal defence and healing is also becoming increasingly
clear, although the mechanism needs to be further eluci-
dated.8 12 More recently, it has been found that the expression
pattern of mucins and TFF peptides alters in gastric
precancerous lesions and neoplasia, and these altered
expression patterns may be used as prognostic indicators,
implying involvement of these factors in tumour progres-
sion.3 7 8 11–18
Helicobacter pylori is recognised as a major cause of chronic
gastritis and peptic ulcer disease, and is a definite pathogen
for the development of gastric cancer.19–21 However, the exact
mechanisms by which infection with the organism leads to
gastric cancer have not been fully elucidated. Previous studies
have shown that H pylori infection is associated with changes
in the expression of mucins in the gastric epithelium.3–5
However, these studies only investigated gastric biopsies
taken from the gastric antrum, so that global changes in the
expression of these factors in the stomach could not be
revealed. Moreover, the possible changes in gastric epithelial
expression of TFF2 in the presence of H pylori infection have
rarely been reported.22 In addition, our previous studies have
shown that H pylori infection is associated with antralisa-
tion—that is, the presence of antral-type mucosa in the
gastric incisura, body, and/or fundus or gastric mucosal
transformation from transitional or body type to antral type,
which is strongly associated with gastric atrophy and
intestinal metaplasia.23 Moreover, cell proliferation and
apoptosis and their related proteins such as Bcl-2 and Bax
alter in the antralised gastric incisura.24 These observations
suggest that antralisation is primarily the result of H pylori
infection in most cases, and may be an important step (or
histological marker) in the process of gastritis progressing to
precancerous lesions. However, whether or not TFF2 and
mucins are involved in antralisation is unknown. Therefore,
the aim of our study was to determine the expression of TFF2
and MUC6 in normal and H pylori infected gastric epithelium
at the gastric antrum, incisura, and body, and to explore the
association between the aberrant expression of TFF2 and
MUC6 and antralisation at the incisura.
PATIENTS AND METHODS
Patients and gastric biopsies
Seventy six patients (M/F, 35/41; mean age, 42; SD, 13 years)
referred for upper endoscopy at Queen Mary Hospital, Hong
Abbreviations: CI, confidence interval; OR, odds ratio; SPEM,
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Kong because of dyspeptic and reflux symptoms were
selected for our study. At endoscopy, four biopsies were
obtained from each patient: two from the gastric antrum, one
from the body, and one from the incisura. One antral biopsy
was used for an in house rapid urease test. The other biopsies
were fixed in formalin and embedded in paraffin wax for
histological examination and immunohistochemistry. The
following groups of patients were excluded from our study:
(1) those who had been taking aspirin or non-steroidal anti-
inflammatory drugs over the past six months; (2) those who
had been taking antibiotics, H2 receptor blockers, bismuth, or
proton pump inhibitors in the preceding four weeks; and (3)
those who had undergone previous gastric surgery, those
with endoscopic evidence of gastroduodenal ulceration, or
those with histological evidence of gastric precancerous
lesions (atrophy, intestinal metaplasia, and dysplasia),
gastric carcinoma, or lymphoma.
All patients gave informed written consent, and this project
was approved by the ethics committee of The University of
Hong Kong.
Detection of H pylori infection and histological
examination
Sections (4 mm thick) of the paraffin wax embedded tissue
were stained with haematoxylin and eosin. Histological
changes and helicobacter-like organisms were examined by
experienced pathologists who were blinded to all clinical and
endoscopic information. The in house rapid urease test used
in our study has been shown to have a sensitivity of 99% and
specificity of 100% for the detection of H pylori.25 Patients
were defined as H pylori positive if positive by both the rapid
urease test and histology. Patients were defined as H pylori
negative if all tests were negative. Patients positive by the
rapid urease test only or histology only were not included in
our study.
The updated Sydney system was used to assess the severity
and activity of gastric inflammation.26 Chronic gastritis was
said to be definitely present when the severity of inflamma-
tion at any site of the stomach was classified as grade 2 or 3.
The mucosa of gastric biopsies taken from different sites was
classified as antral (mucous secreting or pyloric) type, body
(acid secreting or oxyntic) type, or transitional (junctional)
type according to the definitions set out in the updated
Sydney system.26 The characteristic feature of antral-type
mucosa is the presence of coiled and branching antral glands,
which are lined by mucous cells that are interspersed with
endocrine cells (chiefly G and D types), and a few parietal
cells. The glands in body-type mucosa are straight tubes that
constitute acid producing parietal cells, along with scattered
mucous cells in their upper portion and mainly chief cells in
their lower portion, with scattered argyrophilic endocrine
cells. Transitional-type mucosa is a mixture of the architec-
tural features and cell types found in the antral and body
types.26
Immunohistochemistry for TFF2 and MUC6 in gastric
epithelium
Biopsy specimens taken from the antral, body, and incisura
of all patients were subjected to immunohistochemistry for
the assessment of TFF2 and MUC6 expression in the gastric
epithelium. Briefly, tissues embedded in paraffin wax were
cut into sections 4 mm thick, dewaxed, and dehydrated for 10
minutes. The sections were treated in 3% hydrogen peroxide
for five minutes, and then incubated with monoclonal
antibody against TFF2 (undiluted), MUC6 (diluted 1/100;
both from Novocastra Laboratories Ltd, Newcastle upon
Tyne, UK) overnight at 4 C˚, followed by the application of
biotinylated link antibody and streptavidin–horseradish
peroxidase (LSAB kit; Dako Corporation, Carpinteria,
California, USA). Finally, the sections were developed with
diaminobenzidine–hydrogen peroxidase substrate, and
lightly counterstained with haematoxylin.
The intensity of cytoplasmic immunostaining for TFF2 and
MUC6 was scored as follows: 0, negative; 1+, weak; 2+,
moderate; and 3+, strong. Cells with moderate or strong
immunostaining were classed as positively stained. In
addition, the percentage of positively stained cells over the
total number of cells counted was calculated. TFF2 and
MUC6 expression in the gastric foveola was defined as
present when the percentage of positively stained cells over
the total number of foveolar cells counted (. 300) was
> 5%. Because it has been found that TFF2 and MUC6 are
expressed ubiquitously in the regenerative zone of the gastric
mucosa, the expression of TFF2 and MUC6 only in the deeper
gastric glands outside the regenerative zone was measured in
our study, and was defined as present if the percentage of
positively stained cells over the total number of cells counted
(. 300) within these glands was > 5%.
Figure 1 The expression of trefoil
family factor 2 (TFF2) and MUC6 in
normal antral mucosa. There is uniform
staining of (A) TFF2 and (B) MUC6 in
the regenerative zone and the deeper
mucous glands (arrows). Original
magnification,6100.
Figure 2 The expression of trefoil family factor 2 (TFF2) and MUC6 in
normal body mucosa. The expression of (A) TFF2 and (B) MUC6 is
limited to the mucous neck cells in the regenerative zone (arrows).
Original magnification,6100.
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Statistical analysis
Data were expressed as the percentage of positive cases over
the total number of cases. Statistical analysis was performed
using SPSS system (version 10.0; SPSS Inc, Chicago, Illinois,
USA). The association between the expression of TFF2 and
MUC6 and H pylori infection at different gastric sites was
assessed using the x2 test, with Yates’s correction if required,
or Fisher’s exact test; odds ratios (OR), 95% confidence
intervals (CI), and two tailed p values were calculated. The a
level of significance was set at p , 0.05.
RESULTS
Expression of TFF2 and MUC6 in normal gastric
epithelium at different gastric sites
In the normal stomach, staining for TFF2 and MUC6 in the
gastric foveola was very weak or not discernable. In the
gastric antrum, there was uniform staining of TFF2 and
MUC6 in the regenerative zone and the deeper mucous
glands (fig 1). In gastric body mucosa, TFF2 and MUC6 were
expressed together only in the regenerative zone, where
mucous neck cells were present (fig 2). In gastric incisura
mucosa, the expression of TFF2 and MUC6 was limited to the
regenerative zone in most cases (fig 3; table 1).
Expression of TFF2 and MUC6 in H pylori infected
gastric epithelium at different gastric sites
Of the 76 patients, 27 were positive for H pylori infection.
Chronic gastritis (grade 2 or 3) was present in 25 H pylori
positive patients and four H pylori negative patients.
In general, H pylori infection was associated with increased
expression of TFF2 and MUC6 in both the gastric foveola and
the deeper gastric glands at the antrum (fig 4), body (fig 5),
and incisura (fig 6). Foveolar staining for TFF2 and MUC6
appeared to be limited to the bottom of the pits.
In H pylori negative patients, the positive rate for TFF2
expression in the foveola at the antrum, incisura and body
was 4.1%, 2.0%, and 4.1%, respectively. However, in H pylori
infected patients, the rates increased to 59.3%, 44.4%, and
14.8%, respectively. TFF2 expression in the foveola was seen
more often in patients with H pylori infection than in those
without H pylori infection at the gastric antrum (OR, 34.2;
95% CI, 6.83 to 171.0; x2 = 29.30; p , 0.001) and incisura
(OR, 38.4; 95% CI, 4.61 to 320.2; x2 = 19.19; p , 0.001;
table 1). In H pylori positive patients, TFF2 expression in the
deeper glands was present in 100%, 85.2%, and 14.8% of cases
at the antrum, incisura, and body, respectively, whereas the
rates were 100%, 22.4%, and 2.0%, respectively, in those
without H pylori infection. The positive rate for TFF2
expression in the deeper glands at the incisura was
significantly higher in H pylori infected patients than in
uninfected patients (OR, 19.9; 95% CI, 5.66 to 69.8;
x2 = 27.71; p , 00.01; table 1).
MUC6 expression was similar to TFF2 expression (table 1).
In the foveola, MUC6 expression was significantly higher in
H pylori positive patients than in H pylori negative patients at
the antrum (63.0% v 4.1%; OR, 40.0; 95% CI, 7.94 to 201.1;
x2 = 32.19; p , 0.001) and incisura (48.1% v 0%;
x2 = 25.17; p , 0.001). In the deeper glands, MUC6
expression was present more frequently in H pylori positive
patients than in H pylori negative patients at the incisura
(85.2% v 22.4%; OR, 19.9; 95% CI, 5.66 to 69.8; x2 = 27.71;
p , 0.001; table 1).
Association between the expression of TFF2 and
MUC6 and antralisation of gastric incisura
Antral-type mucosa was present at the incisura in 28 of 76 of
patients—20 of the 27 H pylori positive and eight of the 49
H pylori negative patients (table 1). Seventy two patients had
antral-type mucosa and four patients had transitional-type
mucosa in the antrum. At the gastric body, antral-type
mucosa was seen in only one H pylori positive patient and the
transitional type in six (three H pylori positive and three
H pylori negative) patients (table 1).
At the gastric incisura, the expression of TFF2 and MUC6
was significantly associated with the presence of antral-type
mucosa. The rates of TFF2 and MUC6 expression in the
Figure 3 The expression of trefoil
family factor 2 (TFF2) and MUC6 in
normal incisura mucosa. The mucosa
exhibits transitional or body-type
histology, and the expression of (A)
TFF2 and (B) MUC6 is limited to the
mucous neck cells (arrows) in most
cases. Original magnification,6100.
Table 1 Expression of trefoil family factor 2 (TFF2) and MUC6 in Helicobacter pylori positive and negative patients at different
gastric sites in relation to the mucosal types
Percentage of cases with positive TFF2/MUC6 staining
Antrum Incisura Body
N Foveola Gland N Foveola Gland N Foveola Gland
H pylori negative 49 4.1/4.1 100/100 49 2.0/0 22.4/22.4 49 4.1/2.0 2.0/2.0
Antral type 45 4.4/4.4 100/100 8 0/0 75.0/75.0 0 NA NA
Transitional type 4 0 100/100 28 3.6/0 17.9/17.9 3 0/0 0/0
Body type 0 NA NA 13 0/0 0/0 46 4.3/2.2 2.2/2.2
H pylori positive 27 59.3*/63.0* 100/100 27 44.4*/48.1* 85.2*/85.2* 27 14.8/14.8 14.8/11.1
Antral type 27 59.3/63.0 100/100 20 55.0/60.0 100/100 1 100/100 100/100
Transitional type 0 NA NA 6 16.7/16.7 50.0/50.0 3 33.3/33.3 66.7/66.7
Body type 0 NA NA 1 0/0 0/0 23 8.7/8.7 4.3/0
*p,0.001, compared with H pylori negative cases; p,0.001, compared among antral type, transitional type, and body type, x2 test, df = 2.
df, degrees of freedom; NA, not available.
TFF2 and MUC6 in Helicobacter pylori infection 863
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foveola were 39.3%, 5.9%, and 0%, respectively, in antral-
type, transitional-type, and body-type mucosa (degrees of
freedom = 2; x2 = 43.74; p , 0.001). In the deeper glands,
the rates of TFF2 and MUC6 expression were 92.9%, 23.5%,
and 0%, respectively, in antral-type, transitional-type, and
body-type mucosa (degrees of freedom = 2; x2 = 15.62;
p , 0.001). When patients with and those without H pylori
infection were analysed separately, there was an association
between the presence of antral-type mucosa and the
expression of TFF2 and MUC6 in the deeper glands, but
not in the foveola (table 1).
DISCUSSION
Our present study showed that H pylori infection was
associated with significant changes in the expression of
TFF2 and MUC6 at the gastric antrum, incisura, and body. In
the normal gastric antrum, there was no expression of TFF2
and MUC6 in the foveolar epithelium. Both TFF2 and MUC6
were expressed in the regenerative zone and the deeper
portion of the antral glands. These findings are in agreement
with previous studies using antral biopsies.3–5 Moreover, we
found that TFF2 and MUC6 were expressed only in the
regenerative zone of the body mucosa, and, in most cases, of
the incisura mucosa. However, in the presence of H pylori
infection, the distribution of TFF2 and MUC6 expression was
altered: these molecules were frequently expressed in the
foveola of the antrum and incisura. This finding supports the
previous observation by Byrd et al, who only used antral
biopsies, that MUC6 expression was limited to the mucous
glands of H pylori negative patients, but that 72% of H pylori
positive patients expressed MUC6 in the surface mucous
cells.3 Moreover, our present study showed that both TFF2
and MUC6 were also expressed in the deeper glands of the
body, especially the incisura mucosa, in the presence of
H pylori infection.
TFF2 is upregulated in diverse pathological conditions, and
its expression profile broadens to include the regenerative
epithelia of the entire gastrointestinal tract.27 For example,
expression of TFF2 and other trefoil peptides is increased at
sites of gastric ulceration, duodenal ulceration, and Crohn’s
disease.28–30 Thus, increased expression of TFF2 may be a
potentially important mucosal defence mechanism. Previous
studies have shown that there is an association between TFFs
and mucins.1 9–11 TFFs interact with mucous, and stabilise the
mucous gel by binding the long mucous molecules together.17
It has been suggested that TFF2 may function with MUC6 to
strengthen the mucous barrier.17 Moreover, Hoosein et al
showed that a highly purified preparation of porcine TFF2
was able to stimulate [3H] thymidine incorporation in
HCT116 colon carcinoma cells, suggesting a role in cell
proliferation.31 Recently, Farrell et al also showed that TFF2
deficient mice have a 35% reduction in the fundic prolifera-
tion rate compared with wild-type mice.18 Those results
suggest a physiological role for TFF2 in promoting mucosal
healing through the stimulation of cell proliferation.
‘‘Our present study showed that both trefoil family factor 2
and MUC6 were also expressed in the deeper glands of
the body, especially the incisura mucosa, in the presence
of Helicobacter pylori infection’’
Helicobacter pylori infection is associated with antralisation
(or so called pseudopyloric metaplasia) at the gastric incisura,
body, and fundus.23 24 32 It has been established that H pylori
infection induces the apoptosis of gastric epithelial cells, and
subsequently stimulates cell proliferation in the gastric
mucosa.33 Indeed, Wong et al found that resected specimens
taken from the gastric body or fundus, most infected with
H pylori, showed the presence of antral-type glands entirely
surrounded by acid secreting mucosa.34 Moreover, they
reported that there was a pronounced increase of mucous
neck cells in fundus glands adjacent to areas of pseudopyloric
metaplasia, and that the secretory phenotype of pseudopy-
loric metaplasia in the fundus (typically, expression of TFF2)
resembled that of the mucous neck cells.34 These findings
indicate that pseudopyloric metaplasia occurs in the body
glands as a result of hyperplasia of mucous neck cells, and
represents a mucosal response to damage associated with
H pylori infection.23 34 35 Furthermore, Schmidt et al reported
that the spasmolytic polypeptide (TFF2) expressing meta-
plastic (SPEM) lineage was closely associated with fundic
H pylori infection.36 Thus, we propose that the hyperplastic
mucous neck cells move both upwards and particularly
downwards in the oxyntic tubule, replacing the specialised
parietal and chief cells, to create a mucous cell lineage. This
process can occur focally, occupying a single oxyntic tubule,
groups of tubules, or on a fairly massive scale with many
tubules involved.37 Eventually a mucous gland, which
resembles a pyloric gland, is formed, and thus antralisation
of the proximal gastric mucosa, particularly the incisura,
Figure 4 The expression of trefoil
family factor 2 (TFF2) and MUC6 in
antral mucosa with Helicobacter pylori
infection. In addition to the regenerative
zone and the deeper mucous glands,
the expression of (A) TFF2 and (B)
MUC6 is also seen in the foveola
(arrows). Original magnification,
6100.
Figure 5 The expression of trefoil family factor 2 (TFF2) and MUC6 in
body mucosa with Helicobacter pylori infection. The expression of (A)
TFF2 and (B) MUC6 is seen in the regenerative zone and in the deeper
glands (arrows). Original magnification,6100.
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follows. It is most likely that the weakened antralised mucosa
in the proximal stomach is prone to further damage by
H pylori, resulting in ulceration even in the presence of
subnormal acid production.32 38
More importantly, the expression pattern of mucins and
TFFs alters in gastric precancerous lesions and neoplasia, and
thus the altered expression pattern of these factors may be
involved in the development of gastric cancer.2 3 6–8 11–18 39 It
has been shown that mice lacking TFF1 develop antral
adenoma or carcinoma, and TFF1 expression is lost in 50% of
human gastric cancers, suggesting that TFF1 may be a
tumour suppressor gene.8 17 More recently, studies have
shown that SPEM is associated with the development of
gastric cancer, suggesting that SPEM is a potential precursor
lesion of gastric cancer.40 41 In our present study, we found
that alteration of TFF2 and MUC6 expression was associated
with antralisation of gastric incisura, indicating that antra-
lisation is histogenetically identical to SPEM. Because there
was a close topographical association between the expression
of TFF2 and MUC6 in the deeper glands and antralisation of
gastric incisura was present in both H pylori positive and
negative patients, we suggest that the expression of TFF2 and
MUC6 in the deeper glands may be a useful biological marker
for antralisation. Furthermore, based on the findings of
previous and present studies, we hypothesise that the
increased expression of TFF2 and MUC6 in H pylori infection
is a host response to damage induced by the infection. These
factors are associated with the regulation of cell proliferation;
thus, an increase in these factors, along with other growth
factors, will be followed by increased cell proliferation.17 30
However, H pylori induced mucosal damage (including
epithelial apoptosis) that is accompanied by an overmatched
cell proliferation may result in hyperplasia of the gastric
mucosa and transformation of the gastric mucosa into antral-
type mucosa (antralisation), which is believed to increase the
risk of the development of gastric neoplasia.23 24 32 33 Further
studies are required to verify this hypothesis.
In conclusion, H pylori infection increases the expression of
TFF2 and MUC6 in the gastric epithelium, which may be a
protective response of the host to the mucosal damage
induced by H pylori infection. Aberrant expression of TFF2
and MUC6 is associated with antralisation of the gastric
incisura, and thus may be involved in and used as a biological
marker for the process.
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